Why Are Biotech Micro-Caps Like OBD Under Pressure?

Key Reasons Behind the Share Price Decline

Team Kalkine | 24 March 2026

Is Smith & Nephew a hidden defensive gem in the UK stock market?

Is LSE:SN - Smith & Nephew stock rising today due to defensive investing trends and healthcare sector strength?

Ankur Sharma | 24 March 2026

How Does Syncona Create Value in Life Sciences?

OverviewSyncona Limitedis a UK-listed investment trust focused on building and scaling innovative life sciences companies. The firm primarily invests in early-stage and clinical-stage biotechnology businesses, targeting breakthrough therapies across areas such as gene therapy, oncology, and rare diseases. Its model involves identifying promising scientific …

Team Kalkine | 24 March 2026

Should investors consider CVS Group in healthcare portfolios?

CVS Group PLCis one of the largest integrated veterinary service providers in the UK, offering a comprehensive range of services including clinical care, diagnostics, laboratories, and pet crematoria. The company has expanded significantly through acquisitions of independent veterinary practices, building a vertically integrated model …

Team Kalkine | 24 March 2026

Can Healthcare Demand Boost Convatec’s Growth Potential?

Key Reasons Driving Uptick

Team Kalkine | 24 March 2026

Is Hikma Pharmaceuticals a Smart Buy After Today’s Dip?

Why is LSE:HIK - Hikma Pharmaceuticals stock down today on 23 March 2026 despite stable fundamentals?

Ankur Sharma | 23 March 2026

Is Dilution Hurting Trellus Health Stock?

Trellus Health develops digital solutions such as theTrellus Elevateplatform, targeting chronic conditions like inflammatory bowel disease, and operates within theHealthcare – Digital Health / HealthTechsector.

Team Kalkine | 23 March 2026